Us Physicalrapy Stock Performance
| USPH Stock | USD 98.76 1.68 1.73% |
On a scale of 0 to 100, US Physicalrapy holds a performance score of 7. The entity owns a Beta (Systematic Risk) of 2.37, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, US Physicalrapy will likely underperform. Please check US Physicalrapy's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether US Physicalrapy's current price history will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in US Physicalrapy are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, US Physicalrapy demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.73 | Five Day Return 0.28 | Year To Date Return 5.66 | Ten Year Return 152.97 | All Time Return 5 K |
Forward Dividend Yield 0.0178 | Payout Ratio 0.6984 | Last Split Factor 3:2 | Forward Dividend Rate 1.76 | Dividend Date 2024-12-06 |
| US Physicalrapy dividend paid on 13th of September 2024 | 09/13/2024 |
1 | Disposition of 2900 shares by Christopher Reading of US Physicalrapy at 100.26 subject to Rule 16b-3 | 09/30/2024 |
2 | Acquisition by Kathleen Gilmartin of 600 shares of US Physicalrapy at 92.26 subject to Rule 16b-3 | 10/04/2024 |
3 | U.S. Physical Therapy Reports Next Week Wall Street Expects Earnings Growth | 10/29/2024 |
4 | U.S. Physical Therapy Fell on Reduced Guidance | 11/04/2024 |
5 | U.S. Physical Therapy Reports Third Quarter 2024 Results | 11/05/2024 |
6 | U.S. Physical Therapy Trading 15.8 percent Higher on Better-Than-Expected Earnings | 11/06/2024 |
7 | U.S. Physical Therapy, Inc. Q3 2024 Earnings Call Transcript | 11/08/2024 |
8 | Disposition of 2000 shares by Bernard Harris of US Physicalrapy at 92.95 subject to Rule 16b-3 | 11/12/2024 |
9 | Insider Sale Director Harris Bernard A Jr Sells Shares of US Physical Therapy Inc | 11/14/2024 |
10 | US Physical Therapy Inc Shares Up 4.26 percent on Nov 20 | 11/20/2024 |
11 | Disposition of 1128 shares by Richard Binstein of US Physicalrapy at 98.52 subject to Rule 16b-3 | 11/25/2024 |
12 | Acquisition by Bernard Harris of 1600 shares of US Physicalrapy subject to Rule 16b-3 | 11/27/2024 |
| Begin Period Cash Flow | 31.6 M |
USPH |
US Physicalrapy Relative Risk vs. Return Landscape
If you would invest 8,556 in US Physicalrapy on September 2, 2024 and sell it today you would earn a total of 1,320 from holding US Physicalrapy or generate 15.43% return on investment over 90 days. US Physicalrapy is currently generating 0.2562% in daily expected returns and assumes 2.6381% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than USPH, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
US Physicalrapy Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for US Physicalrapy's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as US Physicalrapy, and traders can use it to determine the average amount a US Physicalrapy's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0971
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | USPH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.64 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average US Physicalrapy is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of US Physicalrapy by adding it to a well-diversified portfolio.
US Physicalrapy Fundamentals Growth
USPH Stock prices reflect investors' perceptions of the future prospects and financial health of US Physicalrapy, and US Physicalrapy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USPH Stock performance.
| Return On Equity | 0.0475 | ||||
| Return On Asset | 0.0424 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 1.63 B | ||||
| Shares Outstanding | 15.1 M | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 3.09 X | ||||
| Price To Sales | 2.33 X | ||||
| Revenue | 604.8 M | ||||
| Gross Profit | 112.02 M | ||||
| EBITDA | 74.37 M | ||||
| Net Income | 37.22 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 258.59 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 32.02 X | ||||
| Cash Flow From Operations | 81.98 M | ||||
| Earnings Per Share | 0.88 X | ||||
| Market Capitalization | 1.49 B | ||||
| Total Asset | 997.24 M | ||||
| Retained Earnings | 223.77 M | ||||
| Working Capital | 131.19 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
About US Physicalrapy Performance
By evaluating US Physicalrapy's fundamental ratios, stakeholders can gain valuable insights into US Physicalrapy's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if US Physicalrapy has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if US Physicalrapy has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (2.72) | (2.58) | |
| Return On Tangible Assets | 0.04 | 0.04 | |
| Return On Capital Employed | 0.08 | 0.15 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.03 | 0.03 |
Things to note about US Physicalrapy performance evaluation
Checking the ongoing alerts about US Physicalrapy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for US Physicalrapy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Bernard Harris of 1600 shares of US Physicalrapy subject to Rule 16b-3 |
- Analyzing US Physicalrapy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US Physicalrapy's stock is overvalued or undervalued compared to its peers.
- Examining US Physicalrapy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating US Physicalrapy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US Physicalrapy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of US Physicalrapy's stock. These opinions can provide insight into US Physicalrapy's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |